Viz.ai
Viz.ai develops AI software that analyses medical images to detect time-critical conditions such as large-vessel-occlusion stroke and coordinates the care team in real time, aiming to shorten time to treatment. It became a unicorn in 2022.
- Founded
- 2016
- Headquarters
- San Francisco, California, US
- Founders
- Chris Mansi, David Golan
- Status
- Private
- Total funding
- ~$250M
- Latest round
- Series D, $100M ($1.2B valuation, 2022)
- Valuation
- $1.2B (2022)
- Key investors
- Tiger Global, Insight Partners, Kleiner Perkins, GV
- Category
- Medical imaging AI
- Products
- Viz LVO (stroke), Viz care coordination platform
- Website
- www.viz.ai
Covered in: Artificial Intelligence in Healthcare, Mobile Health and Connected Devices
Profile compiled from the public sources listed above. Funding, valuation, and employee figures are point-in-time and may be out of date.